Follow the people · Insider

DF

Douglas Forsyth

Insider · Director · INBX

Douglas Forsyth files insider transactions with the SEC as a director of Inhibrx (INBX). We hold 1 disclosed purchase or sale filed since 17 August 2007, 1 of them in the last 90 days.

  • Files forINBX
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure8 September 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 21 August 20208 September 2026Director · Inhibrx (INBX)15 Form 4 lines · source: SEC Form 4
  • Filed 29 May 202430 May 2024Director · Inhibrx Biosciences (INXB)2 Form 4 lines · source: SEC Form 4
  • Filed 16 August 200711 August 2020Other role · Nicholas-Applegate Equity & Convertible Income Fund (NIE)50 Form 4 lines · source: SEC Form 4
  • Filed 15 August 200725 June 2014Other role · Nicholas Applegate Convertible & Income Fund (NCV)16 Form 4 lines · source: SEC Form 4

Everything they disclosed

83 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.